source
- Artiva Biotherapeutics cuts 94% of workforce after patient deaths and failed autoimmune cell therapyArtiva Biotherapeutics announced it is halting development of its AlloNK natural killer cell therapy for autoimmune diseases and is laying off roughly 94% of its employees. The AlloNK product, an…
- Labcorp acquires Millennium Health to expand toxicology testing nationwideLabcorp announced it is buying Millennium Health, a specialty laboratory that provides toxicology tests for recent use of prescription medications and illicit drugs. The acquisition is intended to…